Mason; Jonathan Stephen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mason; Jonathan Stephen.The latest application filed is for "cgrp receptor antagonists".

Company Profile

3.13.15

Mason; Jonathan Stephen - Cambridge GB
Mason; Jonathan Stephen - Walmer GB
Mason; Jonathan Stephen - Welwyn Garden GB
Mason; Jonathan Stephen - Welwyn Garden City GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cgrp Receptor Antagonists App 20210213011 - Christopher; John Andrew ; et al.	2021-07-15
1,2,4-triazine-4-amine derivatives Grant 10,988,455 - Congreve , et al. April 27, 2	2021-04-27
CGRP receptor antagonists Grant 10,888,561 - Christopher , et al. January 12, 2	2021-01-12
Cgrp Receptor Antagonists App 20190231773 - Christopher; John Andrew ; et al.	2019-08-01
CGRP receptor antagonists Grant 10,300,056 - Christopher , et al.	2019-05-28
CGRP receptor antagonists Grant 10,259,812 - Christopher , et al.	2019-04-16
1,2,4-triazine-4-amine Derivatives App 20190047978 - Congreve; Miles Stuart ; et al.	2019-02-14
CGRP receptor antagonists Grant 10,166,226 - Christopher , et al. J	2019-01-01
1,2,4-triazine-4-amine derivatives Grant 10,112,923 - Congreve , et al. October 30, 2	2018-10-30
CGRP Receptor Antagonists App 20180153876 - Christopher; John Andrew ; et al.	2018-06-07
CGRP receptor antagonists Grant 9,925,178 - Christopher , et al. March 27, 2	2018-03-27
CGRP Receptor Antagonists App 20180015085 - Christopher; John Andrew ; et al.	2018-01-18
CGRP Receptor Antagonists App 20180009808 - Christopher; John Andrew ; et al.	2018-01-11
CGRP receptor antagonists Grant 9,808,457 - Christopher , et al. November 7, 2	2017-11-07
CGRP receptor antagonists Grant 9,802,935 - Christopher , et al. October 31, 2	2017-10-31
1,2,4-triazine-4-amine Derivatives App 20170291888 - Congreve; Miles Stuart ; et al.	2017-10-12
CGRP Receptor Antagonists App 20170239236 - Christopher; John Andrew ; et al.	2017-08-24
CGRP receptor antagonists Grant 9,688,660 - Christopher , et al. June 27, 2	2017-06-27
Cgrp Receptor Antagonists App 20170121311 - Christopher; John Andrew ; et al.	2017-05-04
CGRP Receptor Antagonists App 20170121331 - Christopher; John Andrew ; et al.	2017-05-04
CGRP Receptor Antagonists App 20170121348 - Christopher; John Andrew ; et al.	2017-05-04
1,2,4-triazine-4-amine Derivatives App 20160175314 - Congreve; Miles Stuart ; et al.	2016-06-23
1,2,4-triazine-4-amine derivatives Grant 9,249,130 - Congreve , et al. February 2, 2	2016-02-02
1,2,4-triazine-4-amine Derivatives App 20150005276 - Congreve; Miles Stuart ; et al.	2015-01-01
1,2,4-triazine-4-amine derivatives Grant 8,809,525 - Congreve , et al. August 19, 2	2014-08-19
1,2,4-triazine-4-amine Derivatives App 20130029963 - Congreve; Miles Stuart ; et al.	2013-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.